January 12, 2021
Good afternoon and thank you for being here today.
This is a day in which we mark another pivotal step forward in the enduring partnership between the United States and Guyana.
This visit builds on the momentum gained by Secretary of State Pompeo and the US International Development Finance Corporation’s recent visits here – and reinforces the US commitment to our shared regional security and the prosperity of the Guyanese people.
The acquisition and cross servicing agreement we signed today, streamlines how our governments efficiently exchange goods or services to support effective – and mutually-beneficial – defense cooperation. With this agreement, we are entering a new era of defense partnership that will strengthen regional stability. Continue reading →
BANNING BUS CRAWLS – in Barbados
What happened when an island with few infections let its guard down
THE ECONOMIST
Barracuda, blue marlin and red snapper were for sale before Christmas at Millie Ifill fish market, but only to those who observed pandemic protocol: “No Mask No Service”, said a large sign. Local discipline and tests on travellers kept COVID-19 cases in Barbados to a trickle. After a lockdown, bars and boutiques were doing brisk business. Reservations at restaurants such as the Fish Pot at Little Good Harbour were becoming hard to get. Locals said the island was in its own little bubble. Continue reading →
LONDON, (Reuters) – Britain became the first country to approve the coronavirus vaccine developed by Oxford University and AstraZeneca, hoping that rapid action will help it stem a record surge of infections driven by a highly contagious form of the virus.
Prime Minister Boris Johnson’s government, which has ordered 100 million doses, had already fast-tracked approval of a vaccine developed by Pfizer and Germany’s BioNTech, and administered hundreds of thousands of shots weeks ahead of European Union countries and the United States. Continue reading →
BEIJING, (Reuters) – December 30, 2020. China approved its first COVID-19 vaccine for general public use today, a shot developed by an affiliate of state-backed pharmaceutical giant Sinopharm, as it braces for greater transmission risks over the winter.
No detailed efficacy data of the vaccine has been publicly released but its developer, Beijing Biological Products Institute, a unit of Sinopharm subsidiary China National Biotec Group (CNBG), said that its vaccine was 79.34% effective in preventing people from developing the disease based on interim data.
Continue reading →
OPINION – Happy New Year 2021 – By Yvonne Sam
In just a matter of hours the year 2021 will be upon us.
While many are looking forward to a brand New Year, we cannot help but regard it as the year when the past will not only be an integral part of the present, but also serve as a visceral reminder of how the unexpected can derail well-planned resolutions, produce stress and halt economic progress—thanks to Covid 19 that unrelenting life taker, and unassailable game changer. Continue reading →
TED Video: What You Can Do To Prevent Alzheimer’s – By Lisa Genova
Alzheimer’s doesn’t have to be your brain’s destiny, says neuroscientist and author of “Still Alice,” Lisa Genova. She shares the latest science investigating the disease — and some promising research on what each of us can do to build an Alzheimer’s-resistant brain.
COVID-19: ‘I’m not an anti-vaxxer, but…’ US health workers’ vaccine hesitancy raises alarm
With up to 40% of frontline workers in LA county refusing Covid-19 inoculation experts warn that understanding and persuasion are needed.
Susan, a critical care nurse based in Alaska, has been exposed to Covid-19 multiple times and has watched scores of people die from the illness. But she did not want to get the vaccination when she learned it would soon be available. Continue reading →
Share this: